<p>Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of Covid-19 vaccine Covishield amid rising numbers of cases of the virus infection.</p>.<p>He said the company already has six million booster doses of Covovax vaccine available and adults must take the booster shot.</p>.<p><strong>Also Read | <a href="https://www.deccanherald.com/state/top-karnataka-stories/covid-preparedness-health-centres-submit-reports-to-karnataka-govt-1208675.html" target="_blank">Covid preparedness: Health centres submit reports to Karnataka govt</a></strong><br /><br />Reacting to reports of Covid-19 vaccines shortage, he said manufacturers are ready but there has been no demand.</p>.<p>"Just as a precaution, at risk we have done it so that people have a Covishield as a choice if they want it," Poonawalla told <em>PTI</em> on restarting of manufacturing of the vaccine.</p>.<p>The company had stopped manufacturing of Covishield in December 2021.</p>.<p>On Covovax which has been approved as a booster dose for 18-years and above, he said, "We have six million doses ready but the demand is exactly zero."</p>.<p>Covovax booster is now on the CoWin app, he said.</p>
<p>Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of Covid-19 vaccine Covishield amid rising numbers of cases of the virus infection.</p>.<p>He said the company already has six million booster doses of Covovax vaccine available and adults must take the booster shot.</p>.<p><strong>Also Read | <a href="https://www.deccanherald.com/state/top-karnataka-stories/covid-preparedness-health-centres-submit-reports-to-karnataka-govt-1208675.html" target="_blank">Covid preparedness: Health centres submit reports to Karnataka govt</a></strong><br /><br />Reacting to reports of Covid-19 vaccines shortage, he said manufacturers are ready but there has been no demand.</p>.<p>"Just as a precaution, at risk we have done it so that people have a Covishield as a choice if they want it," Poonawalla told <em>PTI</em> on restarting of manufacturing of the vaccine.</p>.<p>The company had stopped manufacturing of Covishield in December 2021.</p>.<p>On Covovax which has been approved as a booster dose for 18-years and above, he said, "We have six million doses ready but the demand is exactly zero."</p>.<p>Covovax booster is now on the CoWin app, he said.</p>